David Ferraro

David Ferraro has a diverse work experience spanning over two decades in the pharmaceutical industry. David started their career at Merck as a Primary Care/Hospital Representative, where they worked for six years. David then joined Sanofi as a Senior Hospital Representative for two years before transitioning to Daiichi Sankyo, Inc., where they held various roles, including National Sales Training Manager - Learning & Development, District Sales Manager, and Brand Manager, Marketing.

In 2016, David joined Kyowa Kirin, Inc.- U.S. as an Associate Director, Commercial Sales, Training & Development, where they were responsible for sales training and the successful launch of several products. David later became the National Sales Director - Oncology/Rare Disease, overseeing the Oncology/CNS Sales training team.

In 2021, David joined Calliditas Therapeutics AB as the Head of US Sales, where they played a pivotal role in establishing the sales infrastructure for TARPEYO, the first product indicated for IgA Nephropathy. David collaborated with a Contract Sales Organization to build a sales team and successfully launched the product within nine months, thereafter converting the CSO to direct hires of Calliditas.

Throughout their career, David Ferraro has demonstrated expertise in sales, training, marketing, and leadership roles, contributing to the success of various product launches and executing effective sales strategies.

David Ferraro has a Bachelor of Arts degree in Liberal Arts and Sciences/Liberal Studies from Villanova University. David has attended the University of Valencia and Delbarton School, although no details about degree or field of study are provided for these institutions.